Scholars Central

Conference abstractPublished 28 Nov 2016

Deep sequencing analysis of HBV in chronic HBV patients from Saudi Arabia

Authors: Sherif Aly El-Kafrawy, Ghazi A Jamjoom, Mai M El-Daly, Esam I Azhar

King Abdul Aziz University, KSA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hepatitis B virus (HBV) is a member of the family Hepadnaviridae and is classified into ten genotypes (A-J) and 34 sub-genotypes. These genotypes differ in geographic distribution, HBeAg seroconversion rate, clinical outcome, prognosis and response to antiviral treatment. HBV is transmitted through percutaneous or parenteral routes and is affecting human health all over the world. The prognosis of chronic HBV (CHB) infection includes hepatic failure, cirrhosis and hepatocellular carcinoma (HCC). In the last two decades several studies have been published concerning the epidemiology and prevalence of HBV in Saudi Arabia. However, studies exploring the evolutionary aspect and molecular variations in HBV are very limited. The introduction of mandatory vaccination has reduced the prevalence in young Saudis, <25 years old but the prevalence in individuals of more than 25 years is about 4%. Expatriates working in Saudi Arabia, 33% of the population contributes to the burden of HBV infection in the country. Genotype D is the most prevalent HBV genotype in Saudi Arabia. The molecular characterization of HBV in Saudi Arabia is an urgent need to develop appropriate diagnosis and treatment strategies. The presence of drug resistant mutations in treatment of naive patients has been documented and is shown to be one of the factors affecting the response to antiviral treatment. The best reported approach to investigate the prevalence of these mutations is deep sequencing using next generation sequencing techniques. To approach this point of research, we performed deep sequencing of the virus from chronically infected HBV patients from Saudi Arabia. The results of the Next generation sequencing and the rare mutations found in the samples of the recruited subjects as well as their clinical data will be presented in the presentation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Antivirals & Antiretrovirals.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Antivirals & Antiretrovirals
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sherif Aly El-Kafrawy”
  • BylineArticles whose byline prints “Ghazi A Jamjoom”
  • BylineArticles whose byline prints “Mai M El-Daly”
  • BylineArticles whose byline prints “Esam I Azhar”